Evaluation of Multiple System Atrophy and Early Parkinson's Disease Using ![]() |
Oh, So-Won
(Department of Nuclear Medicine, Seoul National University College of Medicine, Seoul National University Bundang Hospital)
Kim, Yu-Kyeong (Department of Nuclear Medicine, Seoul National University College of Medicine, Seoul National University Bundang Hospital) Lee, Byung-Chul (Department of Nuclear Medicine, Seoul National University College of Medicine, Seoul National University Bundang Hospital) Kim, Bom-Sahn (Department of Nuclear Medicine, Seoul National University College of Medicine, Seoul National University Bundang Hospital) Kim, Ji-Sun (Department of Nuclear Medicine, Seoul National University College of Medicine, Seoul National University Bundang Hospital) Kim, Jong-Min (Department of Neurology, Seoul National University College of Medicine, Seoul National University Bundang Hospital) Kim, Sang-Eun (Department of Nuclear Medicine, Seoul National University College of Medicine, Seoul National University Bundang Hospital) |
1 |
Chinaglia G, Landwehrmeyer B, Probst A, Palacios JM. Serotonergic terminal transporters are differentially affected in Parkinson's disease and progressive supranuclear palsy: an autoradiographic study with [ |
2 | Quinn N. Multiple system atrophy: the nature of the beast. J Neurol Neurosurg Psychiatry 1989;32:1358-63 DOI PUBMED |
3 | Litvan I, Goetz CG, Jankovic J, Wenning GK, Booth V, Bartko JJ, et al. What is the accuracy of the clinical diagnosis of multiple system atrophy? A clinicopathologic study. Acta Neurol 1997;54:937-44 DOI PUBMED ScienceOn |
4 | Benarroche EE, Schmeichel AM, Low PA, Parisi JE. Involvement of medullary serotonergic groups in multiple system atrophy. Ann Neurol 2004;55:418-22 DOI ScienceOn |
5 |
Kim SE, Choi JY, Choe YS, Choi Y, Lee WY. Serotonin transporters in the midbrain of Parkinson's disease patients : a study with |
6 |
Boja JW, Mitchell WM, Patel A, Kopajtic TA, Carroll FI, Lewin AH, et al. High-affinity binding of [ |
7 |
Booij J, Andringa G, Rijks LJ, Vermeulen RJ, De Bruin K, Boer GJ, et al. [ |
8 | Neumeyer JL, Tamagnan G, Wang S, Gao Y, Miliius RA, Kula NS, et al. N-substituted analogs of 2 beta-carbomethoxy-3 beta-(4'-iodophenyl)tropane (beta-CIT) with selective affinity to dopamine or serotonin transporters in rat forebrain. J Med Chem 1996;39:543-8 DOI ScienceOn |
9 |
G |
10 | Halliday GM, Blumbergs PC, Cotton RGH, Blessing WW, Geffer LB. Loss of brainstem serotonin- and substance P-containing neurons in Parkinson's disease. Brain Res 1990;510:104-7 DOI ScienceOn |
11 | Miyawaki E, Meah Y, Koller We. Serotonin, dopamine, and motor effects in Parkinson's disease. Clin Neuropharmacol 1997;20:300-310 DOI ScienceOn |
12 |
Haapaniemi TH, Ahonen A, Torniainen P, Sotaniemi KA, Myllyla VV. [ |
13 |
Neumeyer JL, Wang SY, Milins RA, Baldwin RM, Zea-Ponce Y, Hoffer PB, et al. |
14 | Bannister R, Oppenheimer DR. Degenerative diseases of the nervons system associated with autonomic failure. Brain 1972;95:457-74 DOI ScienceOn |
15 |
Booij J, Habraken JB, Bergmans P, Tissingh G, Winogrodzka A, Wolters EC, et al. Iodine-123 N-omega-fluoropropyl-2 |
16 |
Booij J, Tissingh G, Boer GJ, Speehuan JD, Stoof JC, Janssen AG, et al. [ |
17 | Kaufman MJ, Madras BK Severe depletion of cocaine recognition sites associated with the dopamin transporter in Parkinson's disease striatum. Synapse 1991;9:43-9 DOI PUBMED ScienceOn |
18 | Niznik HB, Fogel EF, Fassos FF, Seeman P. The dopamine transporter is absent in parkinsonism putamen and rednced in caudate nuclens. J Neurochem 1991;56:192-8 DOI PUBMED |
19 | Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992;55:181-4 DOI |
20 | Wenning GK, Ben Shlomo Y, Magalhaes M, Daniel SE, Quinn NP. The clinical features and natural history of multiple system atrophy: an analysis of 100 cases. Brain 1994;117:835-45 DOI ScienceOn |
21 | Booij J, Habraken JB, Bergmans P, Tissingh G, Winogrodzka A, Wolters EC, et al. Imaging of dopamine transporters with iodine-123-FP CIT SPECT in healthy controls and patients with Parkinson's disease. J Nucl Med 1998;39:1879-84 PUBMED |
22 | Wenning GK, Tison F, Ben Shlomo Y, Daniel SE, Quim NP. Multiple system atrophy: a review of 203 pathologically proven cases. Mov Disord 1997;12:133-47 DOI ScienceOn |
23 | Gilman S, Low PA, Quinn N, Albanese A, Ben-Shlomo Y, Fowler CJ, et al. Consensus statement on the diagnosis of multiple system atrophy. J Neurol Sci 1999;163:94-8 DOI ScienceOn |
24 | Feamley JM, Lees A. Striatonigral degeneration. A clinicopathological study. Brain 1990;113:1823-43 DOI ScienceOn |
25 |
Berding G, Br |
26 | Spokes EG, Bannister R, Oppenheimer DR. Multiple system atrophy with autonomic failure: Clinical, histological and neurochemical observations in four cases. J Neurol Sci 1979;43:59-82 DOI ScienceOn |
27 | Tohgi H, Abe T, Takahashi S, Tahahashi J, Hamato H. Concentrations of serotonin and its related substances in the cerebrospinal fluid of Parkinsonian patients and their relations to the severity of symptoms. Neurosci Lett, 1993; 150: 71-4 DOI ScienceOn |
28 |
Patel T, Marek K, Innis RB, Seibyl JP. No difference in 5-HT transporter density in idiopathic Parkinson's disease subjects and healthy controls using |
29 |
Pirker W, Asenbaum S, Bencsits G, Prayer D, Gerschlager W, Deecke L, et al. [ |
30 | Okada T, Fujita M, Shimada S, Sato K, Schloss P, Watanabe Y, et al. Assessment of affinities of beta-CIT, beta-CIT-FE, and beta-CIT-FP for monoamine transporter permanently expressed in cell lines. Nul Med & Biol 1998;35:53-8 ScienceOn |
31 |
Kim YJ, Ichise M, Ballinger JR, Vines D, Erami SS, Tatschida T, et al. Combination of dopamine transporter and |
32 |
Varrone A, Marek KL, Jennings D, Innis RB, Seibyl JP. [ |
33 | Br${\ddot{u}}cke T, Djamshidian S, Bencsits G, Pirker W, Asenbaum S, Podreka I. SPECT and PET imaging of the dopaminergic system in Parkinson's disease. J Neurol 2000;247(suppl 4):2-7 DOI PUBMED |
34 |
Willeit M, Praschak-Rieder N, Neumeister A, Pirker W, Asenbaum S, Vitouch O, et al. |
35 |
Malison RT, Price LH, Berman R, van Dyck CH, Pelton GH, Carpenter L, et al. Reduced brain serotonin transporter availability in major depression as measured by |
![]() |